Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0307746 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Joy Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antiviral Agents, SEER Program. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0).
Abstract (Originalsprache)
Background
Incidence of hepatocellular carcinoma (HCC) had been increasing steadily among older Americans but plateaued in 2015–2017. Chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) are important causes of HCC. The impact of improved treatments for these infections on recent trends in HCC incidence is unclear.
Aims
To examine the relationship between use of antiviral therapy for chronic viral hepatis and HCC incidence in older Americans.
Methods
We used 2007–2017 data from the Surveillance, Epidemiology, and End Results—Medicare database to estimate age-standardized incidence rates and average annual percent changes (AAPCs) for viral hepatitis-attributable HCC among individuals ≥66 years. We analyzed data from Medicare Part D to determine the frequency of HBV and HCV treatment utilization in this population.
Results
Overall HCC incidence increased 10.5%, from 22.2/100,000 in 2007 to 24.5/100,000 in 2017 (AAPC, 1.3%). During that time, HBV-attributable HCC rates decreased from 2.5 to 2.0/100,000 (AAPC, -1.6%), while HCV-attributable HCC rose from 6.6 to 8.0/100,000 (AAPC, 2.0%). HBV treatment among patients with HBV infection increased by 66% (2007, 7.4%; 2015, 12.3%). Treatment for HCV was stable at
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
- Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, United States of America.
- Clinical Research Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, United States of America.
Zitieren
APA
Jiang, J., Shiels, M. S., Rivera, D., Ghany, M. G., Engels, E. A., & O'Brien, T. R. (2024). Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans. PLOS ONE. https://doi.org/10.1371/journal.pone.0307746
Vancouver
Jiang J, Shiels MS, Rivera D, Ghany MG, Engels EA, O'Brien TR. Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans. PLOS ONE. 2024. doi:10.1371/journal.pone.0307746
BibTeX
@article{Jiang2024,
author = {Jiang, Joy and Shiels, Meredith S and Rivera, Donna and Ghany, Marc G and Engels, Eric A and O'Brien, Thomas R},
title = {Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0307746}
}
EUVIMED